An enzyme-linked immunosorbent assay was developed for detection of immunoglobulin A (IgA) 
The widespread use of pertussis vaccine has been followed by a decrease in severity of the disease, but infection is still common, and instances of pertussis are not infrequently seen in clinical practice (18) . Diagnosis on the basis of clinical criteria alone is unreliable, as the presentation may be atypical (9) and other infections sometimes produce signs and symptoms suggestive of pertussis (13) .
Definitive diagnosis is dependent on isolation of Bordetella pertussis, but unless good specimens can be collected early in the disease, the culture may be unsuccessful, even with the improved media (2, 14) now available. Direct fluorescent-antibody staining of nasopharyngeal secretions is a useful diagnostic aid, but lack of sensitivity and problems of interpretation limit its value (3, 10) . Several different serological methods for detection of serum antibody to B. pertussis have been described, but none has proven reliable for diagnosis of active infection (2, 13) . There is still a need for a method to confirm the diagnosis in culture-negative patients.
In pertussis, the bacteria adhere to the ciliated respiratory epithelium, and the infection is essentially superficial (12) , yet there is little available information on the local immune response in the course of the disease (9) . The purpose of the present study was to develop an enzymelinked immunosorbent assay (ELISA) for detection of pertussis immunoglobulin A (IgA) (PsIgA) in nasopharyngeal secretions which would permit assessment of the possible significance of IgA as an indicator of recent infection. MATERIALS Specimens. The specimens examined were nasopharyngeal secretions submitted for pertussis investigation to the diagnostic microbiology laboratory at the Isaak Walton Killam Hospital for Children, Halifax.
They were collected by suction with a fine, flexible plastic catheter (no. 5, French) and syringe. In the laboratory, the specimens were cultured for B. pertussis on charcoal-horse blood agar with and without added cephalexin (40 itg/ml) (15) , smears were prepared for fluorescent-antibody staining for B. pertussis, and the remainder of the specimen was rinsed out of the catheter with 0.5 ml of phosphate-buffered saline and stored at -70°C until the ELISA tests were set up.
The majority of specimens were collected from patients presenting to the emergency or outpatient departments of the hospital and represented sporadic cases of respiratory illness. There was no major outbreak of pertussis or other respiratory illness during this time.
Controls. As a positive control, human pertussis immune globulin (Cutter Laboratories, Berkeley, Calif.) was used. Pooled negative secretions served as a negative control.
Absorption tests. To test for specificity, selected positive secretions were absorbed for 2 h at 37°C with dense, washed, heat-killed suspensions of various organisms. For each absorption test, a duplicate sample of the secretions was diluted in parallel with the ab- Table 1 . B. pertussis was cultured from 57 specimens (16.4%). PsIgA was detected in 8 of the culture-positive and 40 of the culture-negative specimens for a total of 13.8% of specimens. To correlate these results with the stage of disease, the case records of all patients with specimens giving a positive culture or ELISA test were reviewed for information regarding the time of specimen collection in relation to onset of symptoms. Records of 39 patients contained this information, and the results of 46 specimens submitted from these 39 patients are plotted in Fig. 1 . Specimens producing positive cultures were collected 3 to 25 days after onset of symptoms, those positive for PsIgA were collected 6 days to 12 weeks after onset.
The average time between onset of symptoms and specimen collection for the culture-positive, PsIgA-negative specimens was 10 days; for the culture-positive, PsIgA-positive specimens, 15 days; and for the culture-negative, PsIgA-positive specimens, 36 days (Fig. 1) .
In Table 2 , the PsIgA result of these 46 specimens is related to the week of illness. Of 13 specimens collected in the first week of illness, 1 was positive (7.7%) for PsIgA. The positive specimens increased to 41.7% in week 2, 54.6% in week 3, and 100% by weeks 4 to 12.
To determine the specificity of an immunological procedure, the test is usually applied to a series of specimens from known positive and negative patients. In pertussis this is complicated by the problems of diagnosis, both clinical Other evidence for the specificity of the test comes from a review of the case records of patients with a positive PsIgA result. Information was available on 24 such patients (Table 4) Fig. 2 . The results demonstrate the conversion from a negative PsIgA result in the early specimen to a positive result in the followup specimen. In six of these patients, the early specimen was culture positive; in the seventh, a 5-month-old child with croupy cough with chok- ing spells, cyanosis, and vomiting, erythromycin was administered before the first specimen was taken, and cultures were negative.
We have insufficient data to make an accurate assessment of the persistence pattern of PsIgA. Samples collected from four patients 22 to 26 weeks after onset of pertussis had titers that were low (1:2 or 1:4) or negative, suggesting that by 6 months PsIgA production had declined.
Our results indicate that immunization with pertussis vaccine does not give rise to PsIgA in nasopharyngeal secretions. Over 85% of the secretion specimens tested in this study were negative for PsIgA, and many of these specimens came from immunized children. In Table 5 the immunization status of patients in whom PsIgA was detected is compared with that of patients who were PsIgA negative and culture positive.
In both groups, a majority of patients had completed the primary series of three diphtheriapertussis-tetanus inmunizations. Similarly, the children whose results are shown in Fig. 2 had received at least two shots of diphtheria-pertussis-tetanus but their nasopharyngeal secretions were negative for PsIgA when first examined for suspected pertussis infection, further evidence that immunization does not stimulate PsIgA.
DISCUSSION
The superficial localization of B. pertussis to the ciliated epithelium of the respiratory tract suggests that local immunity may be significant in host response to infection. We have demonstrated that the ELISA technique can be used for detection of pertussis IgA and that the presence of IgA in nasopharyngeal secretions corre-VOL. 13 
